Clinical Trial Update: Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

View source ↗

Summary

This entry describes an ongoing clinical trial evaluating the Spectrosense EVA System to detect pancreatic cancer by analyzing volatile organic compounds in exh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Rauscher, Gregory E., M.D. PA | Conditions: Pancreatic Cancer | Status: UNKNOWN